WebMD: Better Information. Better Health.
  • Bookmark This Page
  • Site Map
  • Sign up for WebMD Newsletters

Surgical Menopause & Hormone Therapy

The following is a Sponsored Resource. The sponsor of this content has sole editorial control.
Hormone therapy is not indicated for all women with a hysterectomy or menopausal symptoms.

Learn About Proven Relief in a Tiny Patch

A Patch So Small You'll Hardly Notice It

Vivelle-Dot is an estrogen-only treatment for the relief of moderate to severe menopausal symptoms such as hot flashes and dryness, itching, and burning in and around the vagina, and to help prevent postmenopausal osteoporosis*. It's offered in a range of dosage strengths to help your doctor individualize your treatment for your specific needs. And did we mention that Vivelle-Dot is the smallest estrogen therapy patch available?

Vivelle-Dot Provides:

  • Proven relief of moderate to severe menopause symptoms such as hot flashes and prevention of postmenopausal osteoporosis*
  • Smaller total doses than pills. Patches achieve effective hormone levels with smaller doses compared to pills. This does not mean that patches are safer or more effective
  • The smallest, most discreet estrogen patch available
  • Convenient dosing - twice a week
  • For women interested in the source of estrogen in their therapy, the estrogen in Vivelle-Dot (estradiol) is chemically synthesized from a plant source. This does not mean Vivelle-Dot is safer or more effective than other estrogen products

Small Size and Wearability

Vivelle-Dot is the smallest estrogen therapy patch available today. The 0.05 mg/day patch is the size of a standard postage stamp. In fact, chances are, you'll hardly notice it and neither will anyone else.

Vivelle-Dot is designed to go where you go - even in the swimming pool - without coming off. Vivelle-Dot complimentary non-medicated sample

See for yourself how the Vivelle-Dot patch looks and feels.

When Smaller Will Do

Vivelle-Dot is not only the smallest estrogen patch available – in addition, because the estrogen in Vivelle-Dot is absorbed directly onto your bloodstream through your skin, you can achieve effective hormone levels with smaller total doses compared to pills. This does not mean that Vivelle-Dot is safer or more effective than estrogen pills.

Actual patch sizes

Vivelle-Dot: A Skin-Friendly Patch

Vivelle-Dot has been shown to have a low incidence of skin irritation. Most women apply it and just forget about it until it's time to change it three to four days later!

Quick, Easy Dosing

Women need only apply the Vivelle-Dot patch twice a week for proper dosing and effective relief of their moderate to severe menopause symptoms such as hot flashes and prevention of postmenopausal osteoporosis*.

Thin and Translucent

Vivelle-Dot is a tiny, thin translucent patch. Women apply the inconspicuous patch on the skin of the lower abdomen.

Most Common Side Effects

As with any medication, side effects can occur. The most common side effects with Vivelle-Dot are headache, breast tenderness, and back pain.

View a Video

Interested in learning more about Vivelle-Dot and seeing how it works? Visit the Vivelle-Dot website and view a menopause presentation, called Menopause 101. It introduces three women with whom you may find something in common - menopause. The six-minute casual conversation discusses the risks and benefits of using Vivelle-Dot estrogen therapy to relieve the moderate to severe symptoms of menopause.

Watch the video now
Make sure the sound for your computer is on before you start.
Next Article:

Vivelle-Dot is available by prescription only. Please ask your doctor if Vivelle-Dot is right for you.

(*) Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching, and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin, weak bones); and treat certain conditions in which a young woman’s ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

Important Safety Information

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT VIVELLE-DOT (AN ESTROGEN HORMONE)?

Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).

Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.

You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for Vivelle-Dot Full Prescribing Information

Vivelle-Dot is available by prescription only. Please ask your doctor if Vivelle-Dot is right for you.

Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching, and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman’s ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

Important Safety Information

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT VIVELLE-DOT (AN ESTROGEN HORMONE)?

Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).

Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.

You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.